BRÈVE

sur Viemed Healthcare, Inc. (NASDAQ:VMD)

Viemed Healthcare Reports Record Q2 2026 Financial Results

Graphique de l'évolution du cours de l'action Viemed Healthcare, Inc. (EBR:VMD).

Viemed Healthcare, Inc., a national provider of technology-enabled healthcare solutions, announced its financial results for the second quarter of 2026. The company posted net revenues of $78.1 million, marking a 23.9% increase from the previous year and setting a company record. However, adjusted EBITDA showed a 4.0% decline due to a non-recurring gain in 2025.

Despite this, the company maintained strong operational performance, with net income totaling $2.8 million. Viemed also reported free cash flow of $8.6 million and a cash balance of $10.7 million at the quarter's end. For 2026, the company has adjusted its revenue expectations to between $314 million and $320 million.

The company emphasizes growth across its platforms, including a record increase in ventilator and PAP therapy patients. Viemed's CEO, Casey Hoyt, highlighted the company's momentum, citing solid balance sheets and cash generation as key strengths.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Viemed Healthcare, Inc.